Sarah Boyce Ligand Pharmaceuticals Inc (LGND) insider trading activity

LGND Quotes by TradingView

Sarah Boyce is of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 2,892 shares of LGND, which is worth approximately $327,894. The most recent transaction as insider was on Nov 01, 2022, when has been sold 1,004 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.89K
0% 3M change
0% 12M change
Total Value Held $327,894

Sarah Boyce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2022
SELL
Sale (or disposition) back to the issuer
-
1,004 Reduced 25.77%
2,892 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
1,004 Added 20.49%
3,896 Common Stock
Jun 04 2021
BUY
Grant, award, or other acquisition
-
630 Added 17.89%
2,892 Common Stock

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
President and CEO
BLI
Berkeley Lights, Inc. Healthcare
Director
AHPAW
Avista Public Acquisition Corp. II Financial Services
Director
CTNM
Contineum Therapeutics, Inc.
Director
SB

Sarah Boyce

San Diego, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LGND